'Maintenance therapy' diaporamas de présentation

LMCC Review Lecture Pediatric Respiratory Medicine

LMCC Review Lecture Pediatric Respiratory Medicine. Joe Reisman MD, FRCP(C), MBA Pediatric Respirologist Chief of Pediatrics, CHEO Professor and Chairman, Department of Pediatrics Faculty of Medicine, University of Ottawa. Normal Respiratory Rates. Age Respiratory Rate

1.31k views • 102 slides

Asthma Update

Asthma Update. Suneel Kumar MD. Definition of Asthma. National Asthma Education and Prevention Program (NAEPP) defined as: Airway obstruction that is reversible (but not completely so in some subjects), either spontaneously or with treatment Airway inflammation

1.02k views • 78 slides

ROLE OF MAINTENANCE THERAPY IN ADVANCED CRC

ROLE OF MAINTENANCE THERAPY IN ADVANCED CRC. Cigdem Usul Afsar, MD, Assoc. Prof Ac?badem Mehmet Ali Ayd?nlar University Department of Internal Medicine and Medical Oncology Ac?badem Bak?rkoy Hospital. Presentat?on PLAN. Preface/Introduction Anti-VEGFR based maintenance therapies (Phase 3)

570 views • 56 slides

Raul E. Storey M.D. PGY 5 Fellowship Program Hematology-Oncology Department

Maintenance Chemotherapy in NSCLC. Raul E. Storey M.D. PGY 5 Fellowship Program Hematology-Oncology Department James G. Brown Cancer Center University of Louisville. Advanced NSCLC: Maintenance Therapy.

653 views • 49 slides

Chronic Constipation and Encopresis

Chronic Constipation and Encopresis. Susan Ratliff, MD FAAP April 2, 2009. Constipation. Abnormality in the frequency of defecation or in the size or consistency of the feces Range of symptoms and signs Consider constipation a symptom instead of a diagnosis. Constipation.

707 views • 41 slides

Keynote lecture 5: Priorities for clinical research in GI cancer

Keynote lecture 5: Priorities for clinical research in GI cancer. Daniel G. Haller, MD Professor of Medicine Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania. Establishing a Balance of Priorities.

581 views • 41 slides

Treatment strategies to maximise patient benefit in metastatic colorectal cancer

Treatment strategies to maximise patient benefit in metastatic colorectal cancer. Associate Professor Winston Liauw Cancer Care Centre St George Hospital @ wsliauw. Case discussion.

513 views • 37 slides

580 views • 34 slides

406 views • 27 slides

Tool on Depression: Assessment and Treatment For Older Adults

823 views • 25 slides

Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia. Maggie Davis Hovda 5/26/2009. Definition. Neoplastic disease which results from a mutation in a single lymphoid progenitor cell at one of several discrete stages of development B Cell or T Cell. Epidemiology. Most common childhood acute leukemia, ~80%

920 views • 22 slides

What Does BRCA Have to Do With It? PARP Inhibitors in Ovarian Cancer

What Does BRCA Have to Do With It? PARP Inhibitors in Ovarian Cancer. Program Goals. Ovarian Cancer Overview. PARP Inhibition in Ovarian Cancer. Testing for BRCA1/2 Mutations. PARP Inhibitors Under Development. Olaparib in Patients With BRCA1 / BRCA2 Ovarian Cancer.

594 views • 21 slides

A Comparison of Postoperative Opioid Requirements and Effectiveness in

A Comparison of Postoperative Opioid Requirements and Effectiveness in Methadone-maintained and Buprenorphine-maintained Patients. Dr. R. A. Russell Department of Anaesthesia, Pain Medicine & Hyperbaric Medicine Royal Adelaide Hospital. Opioid Substitution Therapy.

389 views • 20 slides

First Response: NSCLC Highlights From Chicago

First Response: NSCLC Highlights From Chicago. RTOG 0617 Overall Survival Results. ALK Rearrangement Positive Advanced NSCLC. MPDL3280A Phase Ia: Response by PD-L1 IHC Status. GALAXY-1 Overall Survival: Adenocarcinoma. LUME Lung 1: Overall Survival Adenocarcinoma.

329 views • 18 slides

Microscopic Polyangiitis

1.94k views • 17 slides

Multiple Myeloma Examining Maintenance Therapy

Multiple Myeloma Examining Maintenance Therapy. Maintenance Therapy. Case: A 51-Year-Old White Woman. Case: Lab Results. Case: Treatment. Historical Background . Thalidomide. Lenalidomide. Second Primary Malignancies. Proteasome Inhibitors. Does Maintenance Therapy Make a Difference?.

411 views • 16 slides

Robert O. Kumi, Ph.D. Reviewer, Pharmacokinetics

Pharmacokinetic Information Submitted to Support Valganciclovir Use in Maintenance Therapy for CMV Retinitis. Robert O. Kumi, Ph.D. Reviewer, Pharmacokinetics Food and Drug Administration, Office of Clinical Pharmacology and Biopharmaceutics, Division of Pharmaceutical Evaluation III.

259 views • 13 slides

Jaeger U et al. 1 Proc EHA 2013;Abstract P309 . 2 Proc ICML 2013;Abstract 119.

269 views • 12 slides

CASE 2

161 views • 5 slides

MARYLAND AAHAM -

120 views • 0 slides